Our Pricing

Phenergan Syrup: NHS vs Private Treatment Options

Published on: June 03, 2026

When considering phenergan syrup nhs vs private uk pathways for weight management, understanding your treatment options is essential. While Phenergan (promethazine) is an antihistamine not licensed for weight loss, UK patients seeking evidence-based weight management can access prescription treatments through both NHS and private pharmacy routes. At Cured Pharmacy, our UK-registered clinical team provides transparent pricing and rapid access to MHRA-licensed weight loss medications.

Understanding NHS vs Private Weight Loss Treatment Pathways

The NHS provides weight loss medications through GP referral when patients meet specific eligibility criteria, typically requiring a BMI of 30 or above (or 27 with comorbidities) and evidence of previous lifestyle intervention attempts [1]. However, NHS waiting times for specialist weight management services can extend beyond 12 months in many Clinical Commissioning Groups, and medication availability is often restricted to specific formulary options.

Private online pharmacies registered with the General Pharmaceutical Council offer an alternative pathway with several distinct advantages: same-day clinical assessment, access to the latest MHRA-licensed treatments including Mounjaro and Wegovy, transparent upfront pricing, and discreet home delivery within 24-48 hours. All prescription medications still require assessment by a UK-registered prescriber, ensuring the same clinical safety standards apply.

Mounjaro (Tirzepatide): The Dual-Action Weight Loss Treatment

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK for chronic weight management [2]. Unlike single-pathway treatments, tirzepatide activates two natural incretin hormones that regulate appetite, gastric emptying, and glucose metabolism, producing superior clinical outcomes in head-to-head trials.

In the SURPASS-2 trial, patients receiving the 15mg maintenance dose achieved an average 22.5% body weight reduction over 72 weeks — significantly exceeding results from semaglutide-based alternatives [2]. The once-weekly injection schedule and graduated dosing protocol help minimise gastrointestinal side effects during the initial titration period.

Who Can Access Mounjaro Through Private Prescription

Mounjaro is available through Cured Pharmacy for adults with a BMI of 30 or above, or 27 with weight-related health conditions such as type 2 diabetes, hypertension, or obstructive sleep apnoea. Your UK prescriber will assess your medical history, current medications, and contraindications during the free online consultation, which typically takes under three minutes to complete.

Wegovy and Saxenda: Established GLP-1 Treatment Options

Wegovy (semaglutide) and Saxenda (liraglutide) are both GLP-1 receptor agonists with extensive clinical evidence for weight management. Wegovy demonstrated an average 14.9% body weight reduction over 68 weeks in the STEP-1 trial, whilst Saxenda achieved 8% average reduction over 56 weeks in the SCALE study [3][4].

The key difference lies in dosing frequency: Wegovy requires once-weekly injection, whilst Saxenda is administered daily. Both medications work by mimicking the natural GLP-1 hormone, which regulates appetite signals in the brain and slows gastric emptying to increase satiety after meals. Your prescriber will recommend the most appropriate option based on your lifestyle preferences, medical history, and treatment goals.

Comparing Injectable vs Oral Weight Loss Medications

Injectable GLP-1 medications typically produce greater weight loss outcomes compared to oral alternatives like Orlistat, which works by blocking dietary fat absorption in the intestine. Clinical trials show Orlistat achieves approximately 5-8% body weight reduction when combined with calorie restriction, compared to 15-22% with newer injectable treatments [5]. However, oral medications may suit patients with needle aversion or those seeking lower-cost entry points into prescription weight management.

Cost Comparison: NHS Prescription Charges vs Private Pricing

NHS prescription charges in England currently stand at £135.00 per item, though patients in Scotland, Wales, and Northern Ireland receive free prescriptions. However, accessing weight loss medications through the NHS depends entirely on local formulary decisions and clinical eligibility criteria, which vary significantly between regions.

Private pharmacy pricing offers transparency and guaranteed access to specific medications. At Cured Pharmacy, treatment costs are displayed upfront before consultation, with no hidden fees or subscription requirements. Patients can choose between different medication strengths and supply durations to match their budget, and our lowest price guarantee ensures competitive UK market rates across all licensed weight loss treatments.

Clinical Assessment Requirements for Private Prescriptions

All prescription weight loss medications dispensed by UK-registered pharmacies require clinical assessment by a qualified prescriber, regardless of whether obtained through NHS or private routes. At Cured Pharmacy, our online consultation collects comprehensive medical information including current medications, allergies, cardiovascular history, and previous weight loss attempts.

Your assessment is reviewed by a UK-registered prescriber (GMC or NMC registered) who determines medical suitability based on MHRA licensing criteria and NICE guidance. If approved, your prescription is electronically transmitted to our GPhC-registered pharmacy for dispensing. If deemed unsuitable, our clinical team will explain the decision and suggest alternative approaches, with no consultation fees charged.

What Happens After Your Prescription Is Approved

Once your UK prescriber approves treatment, our pharmacy team dispenses your medication in fully discreet packaging with no external branding or product descriptions. All orders are dispatched via Royal Mail Tracked 24 service for next-day delivery across mainland UK. Your package includes full patient information leaflets, dosing instructions, and sharps disposal guidance for injectable medications. Ongoing prescription renewals can be processed through your online patient account with the same clinical oversight.

Choosing Between NHS and Private Weight Loss Treatment Routes

The decision between NHS and private weight loss treatment depends on individual circumstances. NHS routes offer lower upfront costs for eligible patients but involve longer waiting times and limited medication choice based on local formularies. Private pharmacies provide immediate access to the full range of MHRA-licensed treatments with transparent pricing and flexible delivery options.

Many UK patients choose private pharmacies for initial treatment access whilst waiting for NHS specialist appointments, or to access newer medications like Mounjaro that may not yet be available through local NHS services. Both pathways maintain equivalent clinical safety standards, as all UK prescribers must follow the same MHRA licensing criteria and professional guidelines regardless of practice setting [6].

How Cured Pharmacy Ensures Clinical Safety and Transparency

Cured Pharmacy operates under GPhC registration number 9012511, with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical protocols. Our prescribers conduct thorough medical assessments before approving any prescription medication, and our pharmacy team verifies every prescription against patient records before dispensing. We source all medications exclusively from UK-licensed wholesalers, guaranteeing genuine MHRA-approved products with full manufacturer traceability.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE Clinical Guidelines. https://www.nice.org.uk/guidance/cg189 [accessed 13 August 2026]
2. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. Pi-Sunyer, X., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Good practice guidance on the provision of pharmacy services at a distance, including on the internet. MHRA Guidance. https://www.gov.uk/government/publications/good-practice-guidance-on-the-provision-of-pharmacy-services-at-a-distance-including-on-the-internet [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment alongside dietary and lifestyle modifications.